FDA NDC Directory · JSON-LD · Markdown

Inluriyo

NDC 0002-1717 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Generic nameimlunestrant
Labeler / ManufacturerEli Lilly and Company
Marketing categoryNew Drug Application (innovator) · App NDA218881
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsIMLUNESTRANT (200 mg/1)
Marketing started20250925
Package count3

External sources

Source: openFDA. Public-domain (CC0).